Summary:
– The Science of MDMA and its therapeutic uses
– Benefits and Risks of MDMA Usage
– The role of MDMA in treating PTSD and other mental disorders
– The mechanism of action of MDMA in the human brain
– The future of MDMA research and clinical applications
It’s no secret that the human brain is a complex and enigmatic organ. Scientists have been working tirelessly to understand it and find ways to treat its various ailments. One such treatment that has gained attention recently is MDMA, also known as ecstasy. Initially developed as a recreational drug in the 1980s, MDMA has been found to have therapeutic effects in treating mental disorders such as post-traumatic stress disorder (PTSD).
The therapeutic use of MDMA has been much debated in the medical and scientific communities. While some view it as a game-changer in treating mental disorders, others remain skeptical due to its association with recreational use and the potential for abuse. So, what is the science behind MDMA, and what are its benefits and risks?
MDMA is a synthetic drug that alters the levels of neurotransmitters in the brain, including serotonin, dopamine, and norepinephrine. It causes an increase in the levels of these neurotransmitters, resulting in feelings of euphoria and empathy. This mechanism of action is what makes it so popular as a recreational drug but also what makes it potentially helpful in treating mental disorders.
Studies have shown that MDMA-assisted therapy can be effective in treating PTSD. In a small study conducted in 2011, 83% of patients given MDMA during therapy sessions showed significantly reduced PTSD symptoms. MDMA increases a person’s ability to trust others and experience positive emotions. The enhanced feeling of empathy helps individuals to open up and discuss their experiences, which can lead to a reduction in symptoms.
Despite the potential benefits of MDMA, there are also risks associated with its use. The recreational use of MDMA can lead to significant health problems, including dehydration, hyperthermia, and even death in extreme cases. Concerns have been raised about the potential for addiction and long-term changes to brain function with repeated use.
However, when used in a therapeutic setting, under the guidance of trained professionals, the risks associated with MDMA are minimal. In clinical trials, no deaths or serious adverse events have been reported in participants receiving MDMA-assisted therapy.
It’s important to note that MDMA should not be used as a standalone treatment for mental disorders. Instead, it should be an adjunct to traditional therapy techniques, such as cognitive-behavioral therapy (CBT). MDMA-assisted therapy is not a quick fix or appropriate for everyone. It should only be used controlled, safely, and ethically with trained professionals guiding the process.
The potential benefits of MDMA for mental health are just beginning to be explored. Much research must be done to fully understand its mechanisms of action and potential risks. Additionally, regulations around the therapeutic use of MDMA will need to be established before it can become widely available for clinical use.
In conclusion, MDMA has the potential to be a game-changer in the treatment of mental disorders such as PTSD. While its reputation as a recreational drug may cause some to view it skeptically, the science behind its therapeutic effects is compelling. As research in this area continues, we may see MDMA become a valuable tool in the fight against mental illness. However, it’s essential to approach its use cautiously, ensuring it’s only used in controlled, safe, and ethical settings.
*****
Source Description
In this episode, I discuss methylenedioxymethamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applications for the treatment of post-traumatic stress disorder (PTSD), alcohol and other substance-use addictions. I discuss the neuronal mechanisms for how MDMA elevates mood, empathy, motivation, and social engagement and reduces “threat detection” and how these effects can synergistically support talk therapy. I also explain the ongoing debate about the potential neurotoxicity of MDMA, myths about the origins and treatments for post-MDMA “crash,” the evolving legal landscape around MDMA use for clinical purposes, and I caution recreational users about the hazardous additives (e.g., fentanyl) now commonly found in black market MDMA. This should interest those curious about MDMA, neuropharmacology, the origins of emotional processing in the brain, empathy, PTDS, neuroplasticity, mental health, and psychiatry.
#HubermanLab #Science
Thank you to our sponsors
AG1: https://drinkag1.com/huberman
Helix Sleep: https://helixsleep.com/huberman
ROKA: https://roka.com/huberman
HVMN: https://hvmn.com/huberman
LMNT: https://drinklmnt.com/huberman
Momentous: https://livemomentous.com/huberman
Social & Website
Instagram – https://www.instagram.com/hubermanlab
Twitter – https://twitter.com/hubermanlab
Facebook – https://www.facebook.com/hubermanlab
TikTok – https://www.tiktok.com/@hubermanlab
Website – https://hubermanlab.com
Newsletter – https://hubermanlab.com/neural-network
Articles
A Conserved Role for Serotonergic Neurotransmission in Mediating Social Behavior in Octopus: https://bit.ly/3oV8zSl
Effects of MDMA on sociability and neural response to social threat and social reward: https://bit.ly/3NlOYUC
The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity: https://bit.ly/42yMEhl
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA: https://bit.ly/3NlNERM
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans: https://bit.ly/42AF6e0
RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA (“Ecstasy” ): https://bit.ly/3J9PTVU
Science forced to retract the article on “ecstasy”: https://bit.ly/3oRRpVM
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs: https://bit.ly/3P93gcM
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study: https://go.nature.com/3WqI2Zd
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for the treatment of severe PTSD: https://bit.ly/42wqeNP
Books
PIHKAL: A Chemical Love Story: https://amzn.to/45ZY80w
Trauma: The Invisible Epidemic: https://amzn.to/45VdgfA
The Body Keeps the Score: https://amzn.to/3XgH5Dz
Other Resources
Multidisciplinary Association for Psychedelic Studies (MAPS): https://maps.org
Participate in a MAPS trial: https://maps.org/take-action/participate-in-trial
Huberman Lab episode on psilocybin: https://bit.ly/43yP80G
Huberman Lab episode on psychedelics for mental health: https://bit.ly/3NqC3Rz
Huberman Lab episode on dopamine, mindset & drive: https://bit.ly/3IqQzVb
Huberman Lab episode on leveraging dopamine: https://bit.ly/3P3dCuD
Timestamps
00:00:00 MDMA “Ecstasy.”
00:04:37 Sponsors: Helix Sleep, ROKA, HVMN
00:08:18 MDMA History & Synthesis; Legality
00:14:45 MDMA, Methamphetamine (Meth), Dopamine & Serotonin
00:23:30 MDMA vs. Psychedelics vs. Ketamine
00:26:54 MDMA & Serotonin 1B Receptor, Subjective Feelings, Trauma
00:33:36 Sponsor: AG1
00:34:51 Amygdala & Threat Detection, Prosocial Behavior, MDMA Dosages
00:45:48 Interoception, MDMA & Post-Traumatic Stress Disorder (PTSD)
00:52:36 Long-Term Effects, Threat Detection & PTSD
00:56:14 MDMA, Social Connection & Empathy; Meth, SSRIs
01:06:10 Sponsor: LMNT
01:07:22 Oxytocin & MDMA
01:16:10 Safety & Neurotoxicity; Recreational Use, Caffeine & Fentanyl
01:26:36 Is MDMA Neurotoxic?; Poly-Pharmacology, Body Temperature
01:37:07 Post-MDMA “Crash,” Prolactin & P 5 P
01:43:07 PTSD & Trauma; Talk Therapy, SSRIs
01:54:09 PTSD Treatment: Talk Therapy + MDMA
02:02:46 MDMA & Addiction; Dissociative PTSD & Empathy
02:09:47 Side-Effects?, MDMA Efficacy & Legality
02:15:22 Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Social Media, Neural Network Newsletter
Title Card Photo Credit: Mike Blabac – https://www.blabacphoto.com
Disclaimer: https://hubermanlab.com/disclaimer
